Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II dose-finding study of ulipristal for uterine myoma in Japanese women
jRCT2080222667Phase 2
- Sponsor
- ASKA Pharmaceutical Holdings Co., Ltd.
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ulipristal in Fibromyoma (LM) (3 arms), sponsored by ASKA Pharmaceutical Holdings Co., Ltd.
02
Drugs
ulipristal
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on jRCT2080222667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222667.